THU0725-HPR Cost Effectiveness Analysis of Abatacept Compared With TNF Inhibitors in Patients Who Are Positive for Anti-Citrullinated Protein Antibodies Based on Results From an Observational Trial

doi 10.1136/annrheumdis-2017-eular.3436
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism


Related search